Goldman, Butterwick, Fitzpatrick, Groff & Fabi Cosmetic Laser Dermatology, San Diego, CA 92121, USA.
Dermatol Surg. 2012 Jul;38(7 Pt 2):1208-16. doi: 10.1111/j.1524-4725.2012.02476.x.
Poly-L-lactic acid (PLLA) is an effective treatment for panfacial volumization. Typically, patients who are candidates for volume restoration can benefit from lasers and light sources for photorejuvenation.
To evaluate the safety and efficacy of combining PLLA with intense pulsed light (IPL) in facial photorejuvenation.
This was a retrospective, single-center study of 90 patients treated with IPL immediately before or as early as 6 days after PLLA injection from January 2003 and June 2011. Patients were contacted with regard to efficacy and adverse reactions after their treatment.
One hundred fifteen patients had IPL treatments to the face from immediately before to up to 700 days after PLLA injection to the face. Ninety patients responded; 19% experienced edema, 17% bruising, 10% erythema, 7% nodule formation after PLLA injections with 0 nodules occurring after IPL, and 12% mild discomfort during the IPL treatment. The majority of patients (86.7%) reported at least mild photorejuvenating effects from the combination of PLLA and IPL treatments, with 64.4% reporting good to excellent correction independent of number of treatments.
The combination of PLLA with IPL in photorejuvenation of the face is safe and effective.
聚左旋乳酸(PLLA)是一种有效的全面部容积填充治疗方法。通常,适合容积修复的患者可从激光和光能治疗中获益,实现皮肤光老化的治疗。
评估聚左旋乳酸(PLLA)联合强脉冲光(IPL)在面部光老化治疗中的安全性和有效性。
这是一项回顾性、单中心研究,纳入了 2003 年 1 月至 2011 年 6 月间共 90 例接受 PLLA 注射治疗的患者,这些患者在 PLLA 注射后即刻或 6 天内接受 IPL 治疗。在治疗后,对患者进行了疗效和不良反应的随访。
115 例患者在 PLLA 面部注射后即刻至 700 天内接受 IPL 面部治疗。90 例患者做出了回应,19%的患者出现肿胀,17%的患者出现瘀斑,10%的患者出现红斑,7%的患者在 PLLA 注射后出现结节形成,而 IPL 治疗后无结节形成,12%的患者在 IPL 治疗过程中出现轻度不适。大多数患者(86.7%)报告称,联合 PLLA 和 IPL 治疗至少出现了轻度的光老化改善效果,64.4%的患者报告了良好至极好的纠正效果,与治疗次数无关。
在面部光老化治疗中,PLLA 联合 IPL 是安全且有效的。